Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neutropenia in Breast Cancer”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Large-scale testing (Phase 3)Study completedNCT01079676
What this trial is testing

A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer

Who this might be right for
Neutropenia in Breast Cancer
Eurofarma Laboratorios S.A. 220
Not applicableStudy completedNCT02178475
What this trial is testing

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

Who this might be right for
Chemotherapy-induced Febrile Neutropenia
Amgen 943
Large-scale testing (Phase 3)Study completedNCT00837265
What this trial is testing

Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel

Who this might be right for
Chemotherapy-induced Neutropenia
Teva Branded Pharmaceutical Products R&D, Inc. 334
Large-scale testing (Phase 3)Study completedNCT05221593
What this trial is testing

Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients

Who this might be right for
Neutropenia
Al-Azhar University 50
Not applicableStudy completedNCT03433560
What this trial is testing

An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)

Who this might be right for
Breast Cancer FemaleBreast Neoplasm Female
Kyowa Kirin Korea Co., Ltd. 1,300
Early research (Phase 1)Study completedNCT00002866
What this trial is testing

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast CancerNeutropenia
NCIC Clinical Trials Group 50
Not applicableStudy completedNCT02728596
What this trial is testing

S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)

Who this might be right for
Febrile NeutropeniaStage 0 Breast CancerStage 0 Colorectal Cancer+25 more
SWOG Cancer Research Network 3,665
Large-scale testing (Phase 3)Study completedNCT01516736
What this trial is testing

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Who this might be right for
Chemotherapy-induced NeutropeniaBreast Cancer
Sandoz 308
Large-scale testing (Phase 3)Study completedNCT01519700
What this trial is testing

Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim

Who this might be right for
Chemotherapy Associated NeutropeniaBreast Cancer
Sandoz 218
Testing effectiveness (Phase 2)Study completedNCT04477616
What this trial is testing

Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 160
Testing effectiveness (Phase 2)Study completedNCT02005458
What this trial is testing

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy

Who this might be right for
Non Small Cell Lung CancerBreast Cancer
Xiamen Amoytop Biotech Co., Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT02521441
What this trial is testing

A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.

Who this might be right for
Neutropenia
EVIVE Biotechnology 138
Testing effectiveness (Phase 2)Ended earlyNCT03559387
What this trial is testing

Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia

Who this might be right for
Chemotherapy-induced Neutropenia
Prolong Pharmaceuticals 9
Large-scale testing (Phase 3)Study completedNCT04174599
What this trial is testing

Study to Compare the Efficacy and Safety of F-627 and GRAN®

Who this might be right for
Breast CancerNeutropenia
EVIVE Biotechnology 242
Not applicableStudy completedNCT02428114
What this trial is testing

A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)

Who this might be right for
Early Stage Breast Cancer
Ottawa Hospital Research Institute 142
Post-approval studies (Phase 4)Study completedNCT00277160
What this trial is testing

Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Who this might be right for
NeutropeniaBreast CancerLung Cancer+2 more
Amgen 852
Large-scale testing (Phase 3)Study completedNCT03381417
What this trial is testing

Nanogen Pegcyte Clinical Study for the Prevention of CIN in Breast-cancer Patients.

Who this might be right for
Breast Cancer Female
Nanogen Pharmaceutical Biotechnology Joint Stock Company 128
Large-scale testing (Phase 3)Study completedNCT00035594
What this trial is testing

Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy

Who this might be right for
Neutropenia
Amgen 928
Testing effectiveness (Phase 2)Study completedNCT02522234
What this trial is testing

A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Who this might be right for
Neutropenia
EVIVE Biotechnology 15
Testing effectiveness (Phase 2)Study completedNCT01724866
What this trial is testing

Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cancer

Who this might be right for
Neutropenia
Spectrum Pharmaceuticals, Inc 148
Load More Results